drugset / Trial / NCT05207644
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation
NaSingle-groupOpen-labelTreatment
Summary
Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
Timeline
- Start
- 2021-12-09
- Primary completion
- 2022-04-30
- Completion
- 2022-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 30 mg | — |
| Subject | Misoprostol | Other / unclassified | 800 ug | — |